UNCY Stock Analysis: Buy, Sell, or Hold?
UNCY - Unicycive Therapeutics, Inc. Common Stock
$7.12
0.54 (8.21%)
▲
5d:
+7.07%
30d:
+5.01%
90d:
+27.37%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Mar 30, 2026
0d
Smart Money Distribution
UNCY is up 9.9% this week, but smart money is buying puts. Top strike: $5 2026-05-15 with 2,163 OI. Put ratio: 89% View Scanner →
Strength: 8.9/10
Get Alerted When UNCY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: UNCY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: UNCY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.67
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$13.46
47.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UNCY is currently trading at $7.12, which is considered extended relative to its 30-day fair value range of $6.55 to $7.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.7) compared to its historical average (1.1). Remarkably, the market is currently pricing in an annual earnings decline of 13.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, UNCY is in a uptrend. Immediate support is located at $6.04, while resistance sits at $7.44. The stock is showing strong short-term momentum, up 8.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $46.50 (+553.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, UNCY is in a uptrend. Immediate support is located at $6.04, while resistance sits at $7.44. The stock is showing strong short-term momentum, up 8.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $46.50 (+553.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$6.55 -
$7.03
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
55.7%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.2%)
- BULLISH: Trading 553.1% below Wall St target ($46.50)
Fair Price Analysis
30-Day Fair Range
$6.55 -
$7.03
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$6.05
Resistance Level
$7.44
Current Trend
Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.70
Wall Street Target
$46.50
(+553.1%)
Valuation Discount vs History
-13.3% cheaper
PE vs Historical
0.7 vs 1.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.3%
(market-implied from PE analysis)
1-Year Target
$6.41
(-10%)
2-Year Target
$5.77
(-19%)
3-Year Target
$5.19
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1→1)
$8.11
(+14%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 73.0%)
$763.21
(+10619%)
Base:
(SPY PE: 0.7, Growth: 73.0%)
$24.03
(+238%)
Bear:
(PE: 0.6, Growth: 73.0%)
$20.43
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.7 to 1.1
Stabilization Target:
$11.13
(+56.3%)
PE Expansion Potential:
+56.3%
Share & Embed Analysis
Last updated: April 01, 2026 9:21 PM ET
Data refreshes hourly during market hours. Next update: 10:21 PM
Data refreshes hourly during market hours. Next update: 10:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UNCY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 63 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 45 HOLD |
